These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22362908)

  • 1. Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.
    Liu N; Guo JK; Pang M; Tolbert E; Ponnusamy M; Gong R; Bayliss G; Dworkin LD; Yan H; Zhuang S
    J Am Soc Nephrol; 2012 May; 23(5):854-67. PubMed ID: 22362908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling.
    Liu N; He S; Ma L; Ponnusamy M; Tang J; Tolbert E; Bayliss G; Zhao TC; Yan H; Zhuang S
    PLoS One; 2013; 8(1):e54001. PubMed ID: 23342059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
    Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
    Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
    Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
    Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling.
    Zhu Y; Yu C; Zhuang S
    Am J Physiol Renal Physiol; 2020 Feb; 318(2):F375-F387. PubMed ID: 31813251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Elp2 prevents renal fibrosis and inflammation induced by unilateral ureter obstruction (UUO) via inactivating Stat3-regulated TGF-β1 and NF-κB pathways.
    Lu S; Fan HW; Li K; Fan XD
    Biochem Biophys Res Commun; 2018 Jun; 501(2):400-407. PubMed ID: 29723529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.
    Zhang Y; Zou J; Tolbert E; Zhao TC; Bayliss G; Zhuang S
    FASEB J; 2020 Jun; 34(6):7295-7310. PubMed ID: 32281211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective activation of epidermal growth factor receptor in renal proximal tubule induces tubulointerstitial fibrosis.
    Overstreet JM; Wang Y; Wang X; Niu A; Gewin LS; Yao B; Harris RC; Zhang MZ
    FASEB J; 2017 Oct; 31(10):4407-4421. PubMed ID: 28626027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Toll-like receptor 9 attenuates unilateral ureteral obstruction-induced renal fibrosis.
    XIN BM; WANG XX; JIN W; YAN HM; CUI B; ZHANG XW; HUA F; YANG HZ; HU ZW
    Acta Pharmacol Sin; 2010 Dec; 31(12):1583-92. PubMed ID: 21113175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy.
    Liu N; Tolbert E; Ponnusamy M; Yan H; Zhuang S
    J Pharmacol Exp Ther; 2011 Sep; 338(3):758-66. PubMed ID: 21622732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis.
    Li YK; Ma DX; Wang ZM; Hu XF; Li SL; Tian HZ; Wang MJ; Shu YW; Yang J
    Pharmacol Res; 2018 May; 131():102-111. PubMed ID: 29530599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-17A induces renal fibrosis through the ERK and Smad signaling pathways.
    Weng CH; Li YJ; Wu HH; Liu SH; Hsu HH; Chen YC; Yang CW; Chu PH; Tian YC
    Biomed Pharmacother; 2020 Mar; 123():109741. PubMed ID: 31901549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
    Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo silencing of amphiregulin by a novel effective Self-Assembled-Micelle inhibitory RNA ameliorates renal fibrosis via inhibition of EGFR signals.
    Son SS; Hwang S; Park JH; Ko Y; Yun SI; Lee JH; Son B; Kim TR; Park HO; Lee EY
    Sci Rep; 2021 Jan; 11(1):2191. PubMed ID: 33500443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy.
    Chen X; Yu C; Hou X; Li J; Li T; Qiu A; Liu N; Zhuang S
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1003-F1014. PubMed ID: 33103445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of TRPM2 reduces renal fibrosis and inflammation through blocking TGF-β1-regulated JNK activation.
    Wang Y; Chen L; Wang K; Da Y; Zhou M; Yan H; Zheng D; Zhong S; Cai S; Zhu H; Li Y
    Biomed Pharmacother; 2019 Dec; 120():109556. PubMed ID: 31655312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nupr1 mediates renal fibrosis via activating fibroblast and promoting epithelial-mesenchymal transition.
    Zhou R; Liao J; Cai D; Tian Q; Huang E; Lü T; Chen SY; Xie WB
    FASEB J; 2021 Mar; 35(3):e21381. PubMed ID: 33617091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.
    Wu CF; Chiang WC; Lai CF; Chang FC; Chen YT; Chou YH; Wu TH; Linn GR; Ling H; Wu KD; Tsai TJ; Chen YM; Duffield JS; Lin SL
    Am J Pathol; 2013 Jan; 182(1):118-31. PubMed ID: 23142380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR drives the progression of AKI to CKD through HIPK2 overexpression.
    Xu L; Li X; Zhang F; Wu L; Dong Z; Zhang D
    Theranostics; 2019; 9(9):2712-2726. PubMed ID: 31131063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.